Scopus Biopharma Stock Price, News & Analysis
Company Description
Scopus Biopharma (OTC Link: SCPS) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $12.6K.
SCPS stock has gained 33.3% over the past year. Shares last traded at $0.0004.
On a trailing twelve-month basis, Scopus Biopharma reported revenue of $0 and diluted earnings per share of $-0.55.
This page provides a comprehensive overview of SCPS stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Scopus Biopharma (SCPS) stock last traded at $0.0004. Over the past 12 months, the stock has gained 33.3%. At a market capitalization of $12.6K, SCPS is classified as a micro-cap stock with approximately 42.1M shares outstanding.
Latest News
Scopus Biopharma has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 4 with negative movement. Key topics include conferences, management. View all SCPS news →
SEC Filings
Financial Highlights
Diluted earnings per share stood at $-0.55.
Upcoming Events
Short Interest History
Short interest in Scopus Biopharma (SCPS) currently stands at 10.5 thousand shares, representing 0.0% of the float. This relatively low short interest suggests limited bearish sentiment. With 12.3 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for Scopus Biopharma (SCPS) currently stands at 12.3 days, down 44.2% from the previous period. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The days to cover has decreased 97.8% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 1.0 to 553.0 days.
SCPS Company Profile & Sector Positioning
Scopus Biopharma (SCPS) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing SCPS often look at related companies in the same sector, including Virpax Pharmaceuticals Inc (VRPX), Q Biomed (QBIO), Biostax Corp (BTAX), Evelo Biosciences (EVLO), and Renovacare (RCAR). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate SCPS's relative position within its industry.